rs771219955
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_015192.4(PLCB1):c.3172A>G(p.Lys1058Glu) variant causes a missense change. The variant allele was found at a frequency of 0.00000411 in 1,460,756 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015192.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000799 AC: 2AN: 250182Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135188
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1460756Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 726658
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy, 12 Uncertain:1
In summary, this variant is a missense change with uncertain impact on protein function. It has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). The frequency data for this variant (rs771219955) in the population databases is unreliable, as metrics indicate poor quality at this position in the ExAC database. This variant has not been reported in the literature in individuals with a PLCB1-related disease. This sequence change replaces lysine with glutamic acid at codon 1058 of the PLCB1 protein (p.Lys1058Glu). The lysine residue is highly conserved and there is a small physicochemical difference between lysine and glutamic acid. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at